CytoDyn Presents Updated Leronlimab Data at ESMO Congress
The Phase 2 CLOVER study enrolled 66 patients across seven sites in metastatic colorectal cancer.
The Phase 2 CLOVER study enrolled 66 patients across seven sites in metastatic colorectal cancer.